Prolonged inhibition of angiotensin II attenuates glycerol-induced acute renal failure. 1988

R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
Laboratório de Fisiopatologia Renal, Faculdade de Medicina, Universidade de São Paulo, Brasil.

1. A lipophilic competitive angiotensin II antagonist (octanoyl-[8-leucine]-angiotensin II, OCTLEU A-II) was used to partially block the renin-angiotensin system in rats with glycerol-induced acute renal failure. The rats, which were maintained either on a normal or on a low-sodium diet, were dehydrated for 24 h before injection of glycerol. Daily intramuscular injections of OCTLEU A-II in peanut oil were started 48 h before glycerol administration to assure an angiotensin II blockade up to 48 h after glycerol administration. 2. In the low-sodium group (N = 23), acute renal failure was significantly attenuated in OCTLEU A-II-treated rats (N = 9) when compared with the controls (N = 14). The following values (means +/- 1 SD) for renal function parameters were obtained for the treated and control groups: urine volume, 15.2 +/- 11.7 vs 1.4 +/- 2.0 ml/24 h (P less than 0.01); plasma creatinine 5.5 +/- 1.3 vs 8.6 +/- 1.3 mg/dl (P less than 0.01); creatinine clearance 0.23 +/- 0.16 vs 0.03 +/- 0.03 ml min-1 kg-1 (P less than 0.01); plasma potassium 6.6 +/- 1.5 vs 10.1 +/- 1.9 mEq/1 (P less than 0.01); and sodium excretion fraction 3.0 +/- 4.0 vs 21.6 +/- 17.4% (P less than 0.02). Mean arterial blood pressure was 107 +/- 23 mmHg for the OCTLEU A-II-treated animals and 102 +/- 18 mmHg for the controls. 3. The rats on a normal sodium diet (N = 16) developed moderate non-oliguric renal insufficiency. The OCTLEU A-II-treated (N = 8) and control (N = 8) groups did not differ in any of the parameters measured. 4. The present results show that sodium restriction aggravates glycerol-induced acute renal failure and that the renin-angiotensin system participates, since its inhibition at the level of the angiotensin II receptor attenuates the extreme loss of renal function and prevents anuria.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D004039 Diet, Sodium-Restricted A diet which contains very little sodium chloride. It is prescribed by some for hypertension and for edematous states. (Dorland, 27th ed) Diet, Low-Salt,Diet, Low-Sodium,Diet, Salt-Free,Diet, Low Salt,Diet, Low Sodium,Diet, Salt Free,Diet, Sodium Restricted,Diets, Low-Salt,Diets, Low-Sodium,Diets, Salt-Free,Diets, Sodium-Restricted,Low-Salt Diet,Low-Salt Diets,Low-Sodium Diet,Low-Sodium Diets,Salt-Free Diet,Salt-Free Diets,Sodium-Restricted Diet,Sodium-Restricted Diets
D005990 Glycerol A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. 1,2,3-Propanetriol,Glycerin,1,2,3-Trihydroxypropane,Glycerine
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
January 1987, The American journal of physiology,
R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
October 1975, Archives internationales de pharmacodynamie et de therapie,
R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
October 2001, Journal of cardiovascular pharmacology,
R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
March 2015, Renal failure,
R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
July 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation,
R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
July 1995, Renal failure,
R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
September 1988, Kidney international,
R C Abdulkader, and M M Yuki, and A C Paiva, and M Marcondes
April 1980, Kidney international,
Copied contents to your clipboard!